Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 28.98
+0.19 (0.66%)
Jul 21, 2026, 3:00 PM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 12.75 billion as of July 21, 2026. Its market cap has decreased by -13.01% in one year.
Market Cap
12.75B
Enterprise Value
12.78B
Revenue
1.00B
Ranking
n/a
PE Ratio
120.63
Stock Price
28.98
ChartMarket Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 12.75B, a decrease of -67.37%. That is a compound annual growth rate of -14.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.75B | 7.02% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harbin Pharmaceutical Group | 13.37B |
| Zhejiang Jiuzhou Pharmaceutical | 13.30B |
| Shenzhen Hepalink Pharmaceutical Group | 13.15B |
| Guobang Pharma | 13.10B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.93B |
| Henan Lingrui Pharmaceutical | 12.84B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.54B |
| Beijing Aosaikang Pharmaceutical | 12.45B |